Literature DB >> 12467644

Triplex-forming oligonucleotides as modulators of gene expression.

Ramareddy V Guntaka1, Balwantkumar R Varma, Karl T Weber.   

Abstract

Triplex-forming oligonucleotides (TFOs) have gained prominence in the recent years because of their potential applications in antigene therapy. In particular they have been used as (i) inducers of site-specific mutations, (ii) reagents that selectively and specifically cleave target DNA, and (iii) as modulators of gene expression. In this mini-review, we have made an attempt to highlight the characteristics of these TFOs and the effects of various modifications in the phosphate backbone as well as in the purine and pyrimidine moieties, which contribute to the stability and efficiency of triplex formation. Studies to explore the mechanism of down-regulation of transcription of various genes suggest that at least some TFOs exert their effect by inhibiting binding of specific transcription factors to their cognate cis-acting elements. Recent reports indicate the presence of these potential triplex-forming DNA structures in the genomes of prokaryotes and eukaryotes that may play a major role in target site selection and chromosome segregation as well as in the cause of heritable diseases. Finally, some potential problems in the development of these TFOs as antigene therapeutic agents have also been discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12467644     DOI: 10.1016/s1357-2725(02)00165-6

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

Review 1.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

2.  Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene.

Authors:  Subramaniyan Koilan; David Hamilton; Narina Baburyan; Mythili K Padala; Karl T Weber; Ramareddy V Guntaka
Journal:  Oligonucleotides       Date:  2010-09-06

3.  Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells.

Authors:  Jeane M Govan; Rajendra Uprety; James Hemphill; Mark O Lively; Alexander Deiters
Journal:  ACS Chem Biol       Date:  2012-05-11       Impact factor: 5.100

4.  Tandem mass spectrometry of modified and platinated oligoribonucleotides.

Authors:  Adrien Nyakas; Silvan R Stucki; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-23       Impact factor: 3.109

Review 5.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

6.  Effect of DNA target sequence on triplex formation by oligo-2'-deoxy- and 2'-O-methylribonucleotides.

Authors:  Rachel A Cassidy; Nitin Puri; Paul S Miller
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 7.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

Review 8.  Myofibroblast secretome and its auto-/paracrine signaling.

Authors:  Ritin Bomb; Mark R Heckle; Yao Sun; Salvatore Mancarella; Ramareddy V Guntaka; Ivan C Gerling; Karl T Weber
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-02-17

9.  Sequence-specific triple helix formation with genomic DNA.

Authors:  Zhaoyang Ye; Ramareddy V Guntaka; Ram I Mahato
Journal:  Biochemistry       Date:  2007-09-11       Impact factor: 3.162

10.  Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders.

Authors:  Chatchawan Srisawat; David R Engelke
Journal:  Nucleic Acids Res       Date:  2010-08-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.